1
|
Popara J, Accomasso L, Vitale E, Gallina C, Roggio D, Raimondo S, Rastaldo R, Alberto G, Catalano F, Martra G, Turinetto V, Pagliaro P, Giachino C. Silica nanoparticles actively engage with mesenchymal stem cells in improving cardiac pro-regenerative functional effects. Vascul Pharmacol 2018. [DOI: 10.1016/j.vph.2017.12.052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
2
|
Folino A, Accomasso L, Giachino C, Montarolo PG, Losano G, Pagliaro P, Rastaldo R. Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src. Acta Physiol (Oxf) 2018; 222. [PMID: 28748611 DOI: 10.1111/apha.12924] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Revised: 05/31/2017] [Accepted: 07/24/2017] [Indexed: 12/30/2022]
Abstract
AIM Apelin, the ligand of the G-protein-coupled receptor (GPCR) APJ, exerts a post-conditioning-like protection against ischaemia/reperfusion injury through activation of PI3K-Akt-NO signalling. The pathway connecting APJ to PI3K is still unknown. As other GPCR ligands act through transactivation of epidermal growth factor receptor (EGFR) via a matrix metalloproteinase (MMP) or Src kinase, we investigated whether EGFR transactivation is involved in the following three features of apelin-induced cardioprotection: limitation of infarct size, suppression of contracture and improvement of post-ischaemic contractile recovery. METHOD Isolated rat hearts underwent 30 min of global ischaemia and 2 h of reperfusion. Apelin (0.5 μm) was infused during the first 20 min of reperfusion. EGFR, MMP or Src was inhibited to study the pathway connecting APJ to PI3K. Key components of RISK pathway, namely PI3K, guanylyl cyclase or mitochondrial K+ -ATP channels, were also inhibited. Apelin-induced EGFR and phosphatase and tensing homolog (PTEN) phosphorylation were assessed. Left ventricular pressure and infarct size were measured. RESULTS Apelin-induced reductions in infarct size and myocardial contracture were prevented by the inhibition of EGFR, Src, MMP or RISK pathway. The involvement of EGFR was confirmed by its phosphorylation. However, neither direct EGFR nor MMP inhibition affected apelin-induced improvement of early post-ischaemic contractile recovery, which was suppressed by Src and RISK inhibitors only. Apelin also increased PTEN phosphorylation, which was removed by Src inhibition. CONCLUSION While EGFR and MMP limit infarct size and contracture, Src or RISK pathway inhibition suppresses the three features of cardioprotection. Src does not only transactivate EGFR, but also inhibits PTEN by phosphorylation thus playing a crucial role in apelin-induced cardioprotection.
Collapse
Affiliation(s)
- A. Folino
- Department of Clinical and Biological Sciences; University of Turin; Orbassano Italy
| | - L. Accomasso
- Department of Clinical and Biological Sciences; University of Turin; Orbassano Italy
| | - C. Giachino
- Department of Clinical and Biological Sciences; University of Turin; Orbassano Italy
| | - P. G. Montarolo
- Department of Neurosciences; University of Turin; Torino Italy
| | - G. Losano
- Department of Neurosciences; University of Turin; Torino Italy
| | - P. Pagliaro
- Department of Clinical and Biological Sciences; University of Turin; Orbassano Italy
| | - R. Rastaldo
- Department of Clinical and Biological Sciences; University of Turin; Orbassano Italy
| |
Collapse
|
3
|
Folino A, Rolfo A, Montarolo P, Losano G, Rastaldo R. Apelin protects the heart against ischemia–reperfusion injury via epidermal growth factor receptor (EGFR) transactivation. Vascul Pharmacol 2015. [DOI: 10.1016/j.vph.2015.11.034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
4
|
Folino A, Sprio AE, Di Scipio F, Berta GN, Rastaldo R. Alpha-linolenic acid protects against cardiac injury and remodelling induced by beta-adrenergic overstimulation. Food Funct 2015; 6:2231-9. [DOI: 10.1039/c5fo00034c] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
α-Linolenic acid (ALA)-enriched diet prevented isoproterenol (ISO)-induced fibrosis in the ventricular myocardium.
Collapse
Affiliation(s)
- A. Folino
- Department of Clinical and Biological Sciences
- “S. Luigi Gonzaga” Hospital
- University of Turin
- 10043 Orbassano
- Italy
| | - A. E. Sprio
- Department of Clinical and Biological Sciences
- “S. Luigi Gonzaga” Hospital
- University of Turin
- 10043 Orbassano
- Italy
| | - F. Di Scipio
- Department of Clinical and Biological Sciences
- “S. Luigi Gonzaga” Hospital
- University of Turin
- 10043 Orbassano
- Italy
| | - G. N. Berta
- Department of Clinical and Biological Sciences
- “S. Luigi Gonzaga” Hospital
- University of Turin
- 10043 Orbassano
- Italy
| | - R. Rastaldo
- Department of Clinical and Biological Sciences
- “S. Luigi Gonzaga” Hospital
- University of Turin
- 10043 Orbassano
- Italy
| |
Collapse
|
5
|
Di Scipio F, Sprio A, Folino A, Carere M, Salamone P, Yang Z, Berrone M, Prat M, Losano G, Rastaldo R, Berta G. Injured cardiomyocytes promote dental pulp mesenchymal stem cell homing. Biochim Biophys Acta Gen Subj 2014; 1840:2152-61. [DOI: 10.1016/j.bbagen.2014.03.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2013] [Revised: 02/28/2014] [Accepted: 03/05/2014] [Indexed: 02/07/2023]
|
6
|
Folino A, Rastaldo R, Cappello S, Chiribiri A, Pagliaro P, Losano G. Activity of endothelial factors on myocardial inotropy. Minerva Cardioangiol 2011:R05112925. [PMID: 21285922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Both nitric oxide (NO) and endothelins can either increase or decrease myocardial contractility. A positive inotropic effect occurs in response to low NO concentrations, whereas a negative effect is brought about by high concentrations. Activation of protein kinase A and protein kinase G accounts for the increase and decrease in contractility respectively. Basal NO concentration is virtually unknown so that when NO-donors and NOS stimulators add newly released NO, the most frequent effect is a decrease in contractility. This negative inotropic effect represents a protection against the maladaptative activity of the increased production of angiotensin II and cathecholamines in heart failure. Unlike NO, the main effect of endothelins is an increase in contractility. While the increase in contractility is attributed to an activation of Na+/H+ and Na+/Ca2+ exchangers a decrease seems to depend on the triggering of NO-cGMP pathway by endothelin receptors B. Since endothelin concentration increases in several cardiovascular diseases, the blockade of endothelin receptors has been suggested as a therapeutic tool. The study of the endothelial-dependent repolarizing factors revealed the inotropic activity of 14,15 isoform of epoxi-eicosatrienoic acids.
Collapse
Affiliation(s)
- A Folino
- Physiology Division, Department of Neuroscience, University of Turin, Turin, Italy -
| | | | | | | | | | | |
Collapse
|
7
|
Rastaldo R, Cappello S, Folino A, Di Stilo A, Chegaev K, Tritto I, Pagliaro P, Losano G. Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts. J Physiol Pharmacol 2010; 61:21-27. [PMID: 20228411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 04/14/2009] [Accepted: 01/12/2010] [Indexed: 05/28/2023]
Abstract
Nitric oxide (NO) and reactive oxygen species (ROS) are double-edged swords in reperfused hearts. The effects of a NO-donor and an antioxidant compound against ischemia/reperfusion were studied. The compounds were tested separately, as a mixture and as a new hybrid molecule containing both leads. Isolated rat hearts underwent 30 min global ischemia and 2 hrs reperfusion. Compounds were infused either at 1 or 10 microM concentrations during the first 20 min of reperfusion. Hybrid was also tested in the presence of mitochondrial K(+) ATP-sensitive (mKATP) channel blockade by 5-HD (100 microM). Reduction of infarct size and recovery of left ventricular developed pressure during reperfusion were evaluated. When given at 1 microM concentration, hybrid significantly improved all indices of protection; its beneficial effects were abolished by mKATP channel blockade. At the same concentration, mixture and NO-donor alone improved recovery of left ventricular developed pressure but did not reduce infarct size; antioxidant was ineffective. When given at 10 microM concentration, antioxidant and mixture improved all parameters of protection; NO-donor and hybrid were ineffective. Our data suggest that different signaling cascades could be elicited by low and high concentrations of antioxidant compound and/or NO-donor. It is likely that a different NO-induced release of reactive oxygen species via mKATP channel activation may play a pivotal role in affecting infarct size and post-ischemic contractile recovery.
Collapse
Affiliation(s)
- R Rastaldo
- University of Turin, Department of Clinical and Biological Sciences, Turin, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Rastaldo R, Pagliaro P, Cappello S, Penna C, Mancardi D, Westerhof N, Losano G. Nitric oxide and cardiac function. Life Sci 2007; 81:779-93. [PMID: 17707439 DOI: 10.1016/j.lfs.2007.07.019] [Citation(s) in RCA: 164] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2007] [Revised: 07/16/2007] [Accepted: 07/18/2007] [Indexed: 10/23/2022]
Abstract
Nitric oxide (NO) participates in the control of contractility and heart rate, limits cardiac remodeling after an infarction and contributes to the protective effect of ischemic pre- and postconditioning. Low concentrations of NO, with production of small amounts of cGMP, inhibit phosphodiesterase III, thus preventing the hydrolysis of cAMP. The subsequent activation of a protein-kinase A causes the opening of sarcolemmal voltage-operated and sarcoplasmic ryanodin receptor Ca(2+) channels, thus increasing myocardial contractility. High concentrations of NO induce the production of larger amounts of cGMP which are responsible for a cardiodepression in response to an activation of protein kinase G (PKG) with blockade of sarcolemmal Ca(2+) channels. NO is also involved in reduced contractile response to adrenergic stimulation in heart failure. A reduction of heart rate is an evident effect of NO-synthase (NOS) inhibition. It is noteworthy that the direct effect of NOS inhibition can be altered if baroreceptors are stimulated by increases in blood pressure. Finally, NO can limit the deleterious effects of cardiac remodeling after myocardial infarction possibly via the cGMP pathway. The protective effect of NO is mainly mediated by the guanylyl cyclase-cGMP pathway resulting in activation of PKG with opening of mitochondrial ATP-sensitive potassium channels and inhibition of the mitochondrial permeability transition pores. NO acting on heart is produced by vascular and endocardial endothelial NOS, as well as neuronal and inducible synthases. In particular, while in the basal control of contractility, endothelial synthase has a predominant role, the inducible isoform is mainly responsible for the cardiodepression in septic shock.
Collapse
Affiliation(s)
- R Rastaldo
- Department of Neurosciences, Physiology Division, University of Turin, Turin, Italy.
| | | | | | | | | | | | | |
Collapse
|
9
|
Cerra M, Angelone T, Cappello S, Rastaldo R, Quintieri A, Pulerà E, Pagliaro P, Tota B, Losano G. Vasostatin-1: Effects on myocardial contractility and cardioprotection. J Mol Cell Cardiol 2007. [DOI: 10.1016/j.yjmcc.2007.03.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
10
|
Pagliaro P, Cappello S, Rastaldo R, Penna C, Angelone T, Corti A, Tota B, Losano G. Protection against ischemia/reperfusion injures by vasostatin-1 in the isolated rat heart. Comp Biochem Physiol A Mol Integr Physiol 2007. [DOI: 10.1016/j.cbpa.2006.12.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
11
|
Pagliaro P, Penna C, Rastaldo R, Mancardi D, Crisafulli A, Losano G, Gattullo D. Endothelial cytochrome P450 contributes to the acetylcholine-induced cardiodepression in isolated rat hearts. ACTA ACUST UNITED AC 2004; 182:11-20. [PMID: 15329052 DOI: 10.1111/j.1365-201x.2004.01339.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
AIMS Acetylcholine (ACh) is known to reduce the contractility of the heart by acting on myocardial muscarinic M2 receptors. ACh induces also an endothelial-dependent vasodilatation by causing the release of nitric oxide (NO), prostacyclin and endothelium-derived hyperpolarizing factors from the vascular endothelium. It has been proposed that ACh elicits a hyperpolarization of the coronary endothelial cells which may be accompanied by the activation of cytochrome P450 (CYP) and the resulting release of epoxyeicosatrienoic acids (EETs). The study aims at investigating whether endothelial CYP is involved in the cardiodepression by ACh. METHODS AND RESULTS In isolated rat hearts, cardiodepression by ACh (i.e. 25-30% reduction of developed left ventricular pressure) was partially attenuated either by inhibition of CYP with 1-aminobenzotriazole (ABT) or by endothelial dysfunction obtained with Triton X-100. No attenuation of cardiodepression was seen after nitric oxide synthase and cyclooxygenase inhibition by L-nitro-arginine methyl ester and indomethacin, respectively. CONCLUSION The results suggest that the negative inotropic effect of ACh depends not only on a direct myocardial effect but also on the endothelial CYP activation.
Collapse
Affiliation(s)
- P Pagliaro
- Dipartimento di Scienze Cliniche e Biologiche dell'Università di Torino, Orbassano (TO), Italy
| | | | | | | | | | | | | |
Collapse
|
12
|
Pagliaro P, Chiribiri A, Gattullo D, Penna C, Rastaldo R, Recchia FA. Fatty acids are important for the Frank-Starling mechanism and Gregg effect but not for catecholamine response in isolated rat hearts. Acta Physiol Scand 2002; 176:167-76. [PMID: 12392496 DOI: 10.1046/j.1365-201x.2002.01031.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
In some pathophysiological conditions myocardial metabolism can switch from mainly long chain fatty acid (LCFA) oxidation to mainly glucose oxidation. Whether the predominant fatty acid or glucose oxidation affects cardiac performance has not been defined. In a buffer perfused isovolumetrically contracting rat heart, oxidation of endogenous pool LCFA was avoided by inhibiting carnitine-palmitoyl-transferase I (CPT-I) with oxfenicine (2 mM). In order to restore fatty acid oxidation, hexanoate (1 mM), which bypasses CPT-I inhibition, was added to the perfusate. Three groups of hearts were subjected to either an increase in left ventricular volume (VV, +25%) or an increase in coronary flow (CF, +50%), or inotropic stimulation with isoproterenol (10(-8) and 10(-6) m). The increase in VV (the Frank-Starling mechanism) increased rate-pressure product (RPP) by 21 +/- 2% under control conditions, but only by 6 +/- 2% during oxfenicine-induced CPT-I inhibition. The contractile response to changes in VV recovered after the addition of hexanoate. Similar results were obtained in hearts, in which an increase in CF was elicited (the Gregg phenomenon). Isoproterenol caused a similar increase in contractility regardless of the presence of oxfenicine or hexanoate. In all groups, a commensurate increase in oxygen consumption accompanied the increase in contractility. The fatty acid oxidation is necessary for an adequate contractile response of the isolated heart to increased pre-load or flow, whereas the inotropic response to adrenergic beta-receptor stimulation is insensitive to changes in substrate availability.
Collapse
Affiliation(s)
- P Pagliaro
- Dipartimento di Scienze Cliniche e Biologiche, Laboratorio di Fisiologia, dell'Università di Torino, Torino, Italy
| | | | | | | | | | | |
Collapse
|
13
|
Pagliaro P, Rastaldo R, Losano G, Gattullo D. Mitochondrial ATP-sensitive channel opener does not induce vascular preconditioning, but potentiates the effect of a preconditioning ischemia on coronary reactive hyperemia in the anesthetized goat. Pflugers Arch 2001; 443:166-74. [PMID: 11713640 DOI: 10.1007/s004240100673] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2001] [Accepted: 06/26/2001] [Indexed: 11/30/2022]
Abstract
Preconditioning ischemia (PI) increases the speed of the initial vasodilatation (vascular preconditioning) of a subsequent coronary reactive hyperemia (CRH) and reduces total hyperemic flow (THF). We investigated whether changes in CRH similar to those induced by PI are obtained with diazoxide, a mitochondrial ATP-sensitive K+ channel opener, and whether diazoxide influences the effects of a subsequent PI on CRH. In anesthetized goats, flow was recorded from the left circumflex coronary artery (LCCA). CRH and PI were obtained with 15-s and 5-min LCCA occlusions, respectively. CRH was studied before and after PI, before and after diazoxide (2.5 mg/kg i.v.) as well as before and after PI was induced after diazoxide pre-treatment. After PI, the time to peak (ttp) of CRH and THF decreased by 51+/-13% and 23+/-8%, respectively. Diazoxide did not change CRH. After diazoxide and PI, when basal flow had returned to the control level, the ttp of CRH was reduced as after PI alone (-45+/-12%), whereas THF was reduced to a greater extent (-41+/-9% versus -23+/-8%; P<0.01). In conclusion, PI alters CRH by decreasing THF and reducing the ttp of CRH. Whilst diazoxide does not reproduce the effects of PI on CRH, pre-treatment with diazoxide potentiates the effects of PI on THF.
Collapse
Affiliation(s)
- P Pagliaro
- Dipartimento di Scienze Cliniche e Biologiche dell'Università di Torino, Ospedale S. Luigi, Regione Gonzole, 10043 Orbassano, TO, Italy.
| | | | | | | |
Collapse
|
14
|
Pagliaro P, Gattullo D, Rastaldo R, Losano G. Involvement of nitric oxide in ischemic preconditioning. Ital Heart J 2001; 2:660-8. [PMID: 11666094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
In ischemic preconditioning, nitric oxide (NO) limits the extension of a subsequent infarct and protects against ischemia/reperfusion-induced endothelial dysfunction, arrhythmias and myocardial stunning. The protective activity concerns both the first and the second window of protection. The antiarrhythmic effect is attributed to microvessel dilation and to the production of cyclic guanosine monophosphate in the myocardium. The limitation of the infarct size is likely to depend on the opening of the mitochondrial adenosine triphosphate-sensitive potassium channels, to which NO participates via the activation of a protein kinase C (PKC). The endothelial protection involves an NO-mediated reduction in neutrophil adherence to the coronary endothelium and platelet aggregation and is accompanied by an enhanced response to vasodilator stimuli. During preconditioning ischemia, NO is released from the coronary endothelium as a result of bradykinin-induced activation of B2 endothelial receptors. In addition to the early protection, endothelium-derived NO is also responsible for a signaling cascade which leads to the activation of myocardial inducible NO synthase, which in turn is responsible for the release of NO involved in the delayed protection. The signaling cascade includes the activation of PKC-epsilon, tyrosine kinase and some mitogen-activated protein kinases. It has been suggested that the activation of PKC-epsilon is mediated by peroxynitrite produced by the combination of NO and the superoxide anion, the latter being generated during reperfusion which follows preconditioning ischemia.
Collapse
Affiliation(s)
- P Pagliaro
- Department of Clinical and Biological Sciences, University of Turin, Italy.
| | | | | | | |
Collapse
|
15
|
Rastaldo R, Penna C, Pagliaro P. Comparison between the effects of pentobarbital or ketamine/nitrous oxide anesthesia on metabolic and endothelial components of coronary reactive hyperemia. Life Sci 2001; 69:729-38. [PMID: 11476194 DOI: 10.1016/s0024-3205(01)01161-4] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Barbiturates induce reduction of myocardial contractility and metabolism, whereas ketamine exerts a sympathomimetic effect that can mask its direct depressant effect on contractility. However, it is unclear whether barbiturates, which interfere with the cytochrome P-450 pathway, or ketamine, which inhibits nitric oxide synthesis, also alter the responsiveness of the coronary vessels to vasodilator stimuli. We hypothesized that the parameters of coronary reactive hyperemia (CRH), which reflect both the degree of myocardial metabolism and vascular reactivity, could be modified by the type of anesthesia used. In two groups of goats, anesthesia was induced either using ketamine plus nitrous oxide or pentobarbital alone. To record coronary flow an electromagnetic flow-probe was placed around the left circumflex coronary artery. In the ketamine group (n = 14) and in the pentobarbital group (n = 16) CRH was studied using the indices of myocardial metabolism and vascular dilator responsiveness. In the pentobarbital group all of the indices of myocardial metabolism were lower than in the ketamine group (i.e. the excess to debt flow ratio was 2.3+/-0.8 vs. 4.6+/-2.4; p< 0.001). Yet, some indices of vascular responsiveness (time derivative of coronary flow and the peak to basal flow ratio) were not different in the two groups. Moreover, the duration of the reactive hyperemia was shorter in the ketamine than in the pentobarbital group (118+/-47 vs. 153+/-45 s, p<0.05). It is suggested that pentobarbital decreases the indices of CRH related to metabolic activity, whereas ketamine reduces the duration of the hyperemic response, which suggests an impairment of endothelial function.
Collapse
Affiliation(s)
- R Rastaldo
- Dipartimento di Scienze Cliniche e Biologiche, Sezione di Fisiologia, dell'Università di Torino, Italy
| | | | | |
Collapse
|
16
|
Rastaldo R, Paolocci N, Chiribiri A, Penna C, Gattullo D, Pagliaro P. Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect. Am J Physiol Heart Circ Physiol 2001; 280:H2823-32. [PMID: 11356641 DOI: 10.1152/ajpheart.2001.280.6.h2823] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
This study focused on the mechanisms of the negative inotropic response to bradykinin (BK) in isolated rat hearts perfused at constant flow. BK (100 nM) significantly reduced developed left ventricular pressure (LVP) and the maximal derivative of systolic LVP by 20-22%. The cytochrome P-450 (CYP) inhibitors 1-aminobenzotriazole (1 mM and 100 microM) or proadifen (5 microM) abolished the cardiodepression by BK, which was not affected by nitric oxide and cyclooxygenase inhibitors (35 microM NG-nitro-L-arginine methyl ester and 10 microM indomethacin, respectively). The CYP metabolite 14,15-epoxyeicosatrienoic acid (14,15-EET; 50 ng/ml) produced effects similar to those of BK in terms of the reduction in contractility. After the coronary endothelium was made dysfunctional by Triton X-100 (0.5 microl), the BK-induced negative inotropic effect was completely abolished, whereas the 14,15-EET-induced cardiodepression was not affected. In hearts with normal endothelium, after recovery from 14,15-EET effects, BK reduced developed LVP to a 35% greater extent than BK in the control. In conclusion, CYP inhibition or endothelial dysfunction prevents BK from causing cardiodepression, suggesting that, in the rat heart, endothelial CYP products mediate the negative inotropic effect of BK. One of these mediators appears to be 14,15-EET.
Collapse
MESH Headings
- 8,11,14-Eicosatrienoic Acid/analogs & derivatives
- 8,11,14-Eicosatrienoic Acid/metabolism
- 8,11,14-Eicosatrienoic Acid/pharmacology
- Animals
- Arachidonic Acid/metabolism
- Blood Pressure/drug effects
- Bradykinin/metabolism
- Bradykinin/pharmacology
- Coronary Vessels/drug effects
- Coronary Vessels/physiology
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme System/metabolism
- Endothelium, Vascular/drug effects
- Endothelium, Vascular/metabolism
- Enzyme Inhibitors/pharmacology
- Heart/drug effects
- Heart/physiology
- Heart Rate/drug effects
- Heart Rate/physiology
- In Vitro Techniques
- Indomethacin/pharmacology
- Male
- Myocardium/metabolism
- NG-Nitroarginine Methyl Ester/pharmacology
- Nitric Oxide Synthase/antagonists & inhibitors
- Octoxynol/pharmacology
- Proadifen/pharmacology
- Rats
- Rats, Wistar
- Tachyphylaxis/physiology
- Triazoles/pharmacology
- Ventricular Function, Left/drug effects
Collapse
Affiliation(s)
- R Rastaldo
- Dipartimento di Neuroscienze, Sezione di Fisiologia, dell'Università di Torino, 10043 Orbassano, TO, Italy
| | | | | | | | | | | |
Collapse
|
17
|
Abstract
In many species one or more brief coronary occlusions limit the injuries which a subsequent ischemia-reperfusion can produce in the myocardium. A similar protection has been observed in the majority of organ systems. A first period or window of protection can lasts up to 3 hours and is followed by a second window of protection (SWOP) which begins about 24 hours after the brief coronary occlusions and lasts about 72 hours. Increase of the release of endogenous agents such as adenosine and nitric oxide (NO) may be responsible for both windows through the activation of a protein-kinase C (PKC) which in turn activates ATP sensitive potassium (K+(ATP)) channels. Nitric oxide is also reported to act directly on K+(ATP) channels. Recently, it has been suggested that the channels involved in the protection are mitochondrial rather than sarcolemmal. In SWOP the origin of NO is attributed to the activity of an inducible NO-synthase. Free oxygen radicals released during preconditioning are likely to take part in the delayed protection through the production of peroxynitrite which activates PKC and through the increase of the activity of antioxidant enzymes such as Mn superoxide-dismutase. The production of heat shock proteins is considered a marker rather than a mechanism of SWOP.
Collapse
Affiliation(s)
- P Pagliaro
- Dipartimento di Scienze Cliniche e Biologiche dell'Università di Torino, Orbassano, Italy
| | | | | | | |
Collapse
|
18
|
Pagliaro P, Rastaldo R, Paolocci N, Gattullo D, Losano G. The endothelium-derived hyperpolarizing factor: does it play a role in vivo and is it involved in the regulation of vascular tone only? Ital Heart J 2000; 1:264-8. [PMID: 10824726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Several investigations performed in vitro have shown that vascular endothelia can release diffusible compounds capable of inducing hyperpolarization of the smooth muscle fibers. Experiments in vitro have shown that these compounds can cause coronary vasodilation and alter cardiac performance. Experiments in vivo only showed the occurrence of vasodilation. While it has been shown that the release of these endothelium-derived hyperpolarizing factors (EDHFs) is not impaired by the inhibition of nitric oxide synthase and cyclooxygenase, the precise nature of the compound(s) has not yet been identified. It is possible that they vary depending on the organ and animal species. However, a common feature of the activity of EDHFs is the activation of calcium-dependent potassium channels, inhibitable by charybdotoxin and apamin. Furthermore in the coronary circulation of many species EDHF seems to be a cytochrome P450-dependent non-prostanoid metabolite of arachidonic acid activated by a number of chemical and physical stimuli similar to those which are known to activate endothelial nitric oxide synthase. Using compounds which inhibit cytochrome P450 and blockers of the calcium-dependent potassium channels, researchers can study the physiological and pathophysiological relevance of EDHF in vivo thus disclosing the potential therapeutic applications of the basic knowledge in this field.
Collapse
Affiliation(s)
- P Pagliaro
- Department of Clinical and Biological Sciences, University of Turin, Italy.
| | | | | | | | | |
Collapse
|